Home > Products > SIRPα & PSCA > Recombinant Human Anti-SIRPα x Anti-PSCA Bispecific Antibody (Tandem scFv)

Recombinant Human Anti-SIRPα x Anti-PSCA Bispecific Antibody (Tandem scFv)  (CAT#: KN-1025-N33)

Recombinant Anti-SIRPα x Anti-PSCA Bispecific Antibody (Tandem scFv) is designed to be expressed as a scFv from an anti-SIRPα antibody variable domains fused with a scFv from an anti-PSCA antibody variable domains. It contains a His-tag at the C/N terminus for affinity purification. The BsAb exits as monomer in reducing and non-reducing conditions. This BsAb can retarget macrophages to PSCA+ tumor cells. It is designed for the research of Prostate cancer therapy.
Datasheet INQUIRY

Specifications

Targets
SIRPα & PSCA
Type
Tandem scFv
Species Reactivity
Human
Application
FuncS; Promising therapeutic agent
Related Disease
Prostate cancer
Host Animal 1
Human
Host Animal 2
Human

Targets

Target 1
SIRPα
Gene ID
UniProt ID
Alternative Names
SHPS-1; CD172A; p84; MYD-1; BIT; PTPNS1; SIRPA; signal regulatory protein alpha; MFR; P84; MYD1; SIRP; SHPS1; Tyrosine-protein phosphatase non-receptor type substrate 1; SHP substrate 1; Brain Ig-like molecule with tyrosine-based activation motifs; CD172 antigen-like family member A; Inhibitory receptor SHPS-1; Macrophage fusion receptor; MyD-1 antigen; Signal-regulatory protein alpha-1; Sirp-alpha-1; Signal-regulatory protein alpha-2; Sirp-alpha-2; Signal-regulatory protein alpha-3; Sirp-alpha-3
Target 2
PSCA
Gene ID
UniProt ID
Alternative Names
PSCA; prostate stem cell antigen; PRO232
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

See other bsAb targets related to "PSCA"

See other bsAb targets related to "SIRPα"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-SIRPα x Anti-PSCA Bispecific Antibody (Tandem scFv) (KN-1025-N33). Click the button below to contact us or submit your feedback about this product.